# FDA Inspection 1248325 - Apnar Pharma LP - August 16, 2024

Source: https://www.keypedia.com/records/fda_inspections/apnar-pharma-lp/19fe178a-126b-4153-abd0-5edfcf29c834
Source feed: FDA_Inspections

> FDA Inspection 1248325 for Apnar Pharma LP on August 16, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1248325
- Company Name: Apnar Pharma LP
- Inspection Date: 2024-08-16
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/apnar-pharma-lp/679754ca-698a-4ebe-934e-5234d0168848

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c